An investor who currently holds shares of Merge Healthcare Inc. (NASDAQ:MRGE), filed a lawsuit in effort to halt the proposed takeover of Chicago IL based Merge Healthcare Inc. by IBM for $7.13 per share.
Investors who purchased shares of Merge Healthcare Inc. (NASDAQ:MRGE) and currently hold any of those NASDAQ:MRGE shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:MRGE stockholders by agreeing to sell Merge Healthcare Inc. too cheaply via an unfair process to IBM.
On August 6, 2015, IBM (NYSE: IBM) and Merge Healthcare Inc. (NASDAQ:MRGE) announced the signing of a merger agreement pursuant to which IBM will acquire Merge Healthcare Inc. (NASDAQ:MRGE. Under terms of the transaction, Merge shareholders would receive $7.13 per share in cash, for a total transaction value of $1 billion.
However, the plaintiff claims that the proposed consideration NASDAQ:MRGE shareholders will receive is grossly inadequate and undervalues Merge Healthcare Inc. In addition, the plaintiff claims that the process is also unfair to NASDAQ:MRGE stockholders
Those who are current investors in Merge Healthcare Inc. shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com